Researchers studying semaglutide users have reported an observed association between these medications and optic nerve injuries, although ongoing research continues to evaluate causation, underlying risk factors, and the overall frequency of these events
11 In this trial, empagliflozin significantly reduced cardiovascular death by 38% (HR 0.62
This is a significant milestone, as it offers a magnitude of weight loss that rivals the injectable medications, but in a pill form
Although the injury was subclinical, residual effects of repeated exposure over a lifetime might progressively compromise health
CLINICAL TRIAL DATA How They Compare: Efficacy The most important difference between these medications is how much weight they help you lose
Both the unflavored and flavored versions contain only 120 calories, 26 g of protein, and minimal sugar per two-scoop serving